Tuning specificity and topology of lectins through synthetic biology

Author(s)

S. Notova & A. Imberty

Sources

Current Opinion in Chemical Biology 2023, 73:102275 https://doi.org/10.1016/j.cbpa.2023.102275

Lectins are non-immunoglobulin and non-catalytic glycan-binding proteins that are able to decipher the structure and function of complex glycans. They are widely used as biomarkers for following the alteration of glycosylation state in many diseases and have applications in therapeutics. Controlling and extending lectin specificity and topology is the key to obtaining better tools. Furthermore, lectins and other glycan-binding
proteins can be combined with additional domains, providing novel functionalities.
The authors provide their views and analyze the current strategy with a focus on synthetic biology approaches yielding novel specificity, but other novel architectures with novel applications in biotechnology or therapy.
capture-38.png

Latest news

Starch granules offer a unique platform for studying complex, multiresonator lasing phenomena, highlighting the importance...

Cyclodextrins (CDs) are known for their ability to form supramolecular interactions with a wide range...

Lactobacillus displacement from the vaginal microbiome associates with adverse health outcomes and is linked to...

Studies on glycans of glycoproteins are hampered by the lack of standards that reflect the...